Geode Capital Management, LLC Infla Rx N.V. Transaction History
Geode Capital Management, LLC
- $1.26 Trillion
- Q4 2024
A detailed history of Geode Capital Management, LLC transactions in Infla Rx N.V. stock. As of the latest transaction made, Geode Capital Management, LLC holds 48,136 shares of IFRX stock, worth $90,495. This represents 0.0% of its overall portfolio holdings.
Number of Shares
48,136
Previous 36,236
32.84%
Holding current value
$90,495
Previous $55,000
116.36%
% of portfolio
0.0%
Previous 0.0%
Shares
16 transactions
Others Institutions Holding IFRX
# of Institutions
34Shares Held
13.6MCall Options Held
30.9KPut Options Held
2.1K-
Suvretta Capital Management, LLC New York, NY5.73MShares$10.8 Million0.59% of portfolio
-
683 Capital Management, LLC New York, NY2.07MShares$3.89 Million0.37% of portfolio
-
Morgan Stanley New York, NY2.04MShares$3.83 Million0.0% of portfolio
-
Northern Trust Corp Chicago, IL667KShares$1.25 Million0.0% of portfolio
-
Raymond James Financial Inc St. Petersburg, FL638KShares$1.2 Million0.0% of portfolio
About InflaRx N.V.
- Ticker IFRX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 44,203,800
- Market Cap $83.1M
- Description
- InflaRx N.V., a clinical-stage biopharmaceutical company, discovers and develops inhibitors using C5a technology primarily in Germany and the United States. The company's C5a is an inflammatory mediator that is involved in the progression of a variety of autoimmune and other inflammatory diseases. Its lead product candidate is vilobelimab, a nov...